about
Beyond Susceptible and Resistant, Part III: Treatment of Infections due to Gram-Negative Organisms Producing CarbapenemasesInsights into Newer Antimicrobial Agents Against Gram-negative BacteriaThe pharmacological landscape and therapeutic potential of serine hydrolasesStructure of Enterococcus faecium l , d -Transpeptidase Acylated by Ertapenem Provides Insight into the Inactivation MechanismStructural Analysis of the Role of Pseudomonas aeruginosa Penicillin-Binding Protein 5 in -Lactam ResistanceCrystal Structure of the Carbapenem Intrinsic Resistance Protein CarGHis224 Alters the R2 Drug Binding Site and Phe218 Influences the Catalytic Efficiency of the Metallo- -Lactamase VIM-7Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by HalogensCarbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast AsiaUnderstanding the structural mechanisms of antibiotic resistance sets the platform for new discoveryStructural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistanceExploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysisCarbapenemsMolecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme StabilityNew amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharidesIn vivo protein interaction network analysis reveals porin-localized antibiotic inactivation in Acinetobacter baumannii strain AB5075Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic.Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1.Fate and Persistence of a Pathogenic NDM-1-Positive Escherichia coli Strain in Anaerobic and Aerobic Sludge Microcosms.Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda.Seawater is a reservoir of multi-resistant Escherichia coli, including strains hosting plasmid-mediated quinolones resistance and extended-spectrum beta-lactamases genes.Enhanced killing of antibiotic-resistant bacteria enabled by massively parallel combinatorial geneticsAn outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in ItalyApplication of cyclic phosphonamide reagents in the total synthesis of natural products and biologically active molecules.Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patientsQuantification and validation of HPLC-UV and LC-MS assays for therapeutic drug monitoring of ertapenem in human plasma.Unexpected challenges in treating multidrug-resistant Gram-negative bacteria: resistance to ceftazidime-avibactam in archived isolates of Pseudomonas aeruginosa.Acinetobacter calcoaceticus from a fatal case of pneumonia harboring bla(NDM-1) on a widely distributed plasmid.Assays for determination of ertapenem for applications in therapeutic drug monitoring, pharmacokinetics and sample stability.Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.How to treat VAP due to MDR pathogens in ICU patients.Efficient Detection of Carbapenemase Activity in Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Less Than 30 MinutesTriethysilyl Enol Ethers in the Synthesis of Carbapenem Precursors.Molecular detection and antimicrobial resistance of Pseudomonas aeruginosa from houseflies (Musca domestica) in Iran.Rapid detection of porins by matrix-assisted laser desorption/ionization-time of flight mass spectrometry.Fluorogenic probes with substitutions at the 2 and 7 positions of cephalosporin are highly BlaC-specific for rapid Mycobacterium tuberculosis detection.Characterization of BKC-1 class A carbapenemase from Klebsiella pneumoniae clinical isolates in Brazil.Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
P2860
Q26747580-89EFAC25-AC5C-4CFB-829F-3CC7467A5438Q26751255-F3B0E902-DDB0-4BC9-A7B2-D0F41FA4A3A5Q26995817-CCED0D67-6F23-48FF-B0CC-ECD752F85414Q27677294-82C92F77-BE0B-46CD-A659-6C276F39CCEEQ27677851-EA6F9A72-71F9-4E8B-8D5E-1D464490B84EQ27681932-452B5E2C-45F3-4928-9606-69034B469726Q27684253-25A5F781-CF34-4536-A851-29420E616211Q27700611-F2CB88C7-AD92-47DE-BA23-FCB1586F10F1Q28078775-21B4D17C-02B1-484B-9D47-3FBE48F376D1Q28083259-58EA5A65-24B4-4703-931E-8ACA957F2D2DQ28084628-86D7EE03-B389-4E4F-8F00-90E0CBDD28F7Q28272040-695475AF-1B0D-486E-8E0B-0478C1E8006CQ28286055-BF6EFBAD-3300-46EE-B2C8-71410BAFCBB6Q28288964-AD312FC8-7C08-4653-A4F8-ED26A3E31A7DQ28547682-AA25AAD8-F417-471E-A857-69D3211B0DDAQ28654498-89D676F9-0436-4F8C-8F3F-F477DFD2BE65Q28821161-AC58F4A4-D3FD-4B9B-A240-FBB016461AAAQ30620897-122C5276-A58A-4692-AFD3-4FAC0A082AC7Q33649288-9A441E4B-E973-4517-82A2-67AC18F7412BQ33820219-6C47A125-92CB-4AD9-B9D2-463AEB41E82AQ33909415-87F176AD-37B1-45BF-ADA0-B59FD608B32BQ34067802-7B67E9D3-CCA6-4B2B-80BE-85657696B01BQ34119921-A4CE9DB0-BD58-4FB5-BEE8-42E38836156CQ34205018-73B70B49-6600-4B9F-9E25-E11B68CBFF92Q34212287-C633CF8B-DEDD-49E9-B24D-E3109110808BQ34336456-036D1ABD-400F-40A7-933E-C619D0FE6377Q34445380-689F530D-F515-4C19-8B7C-859FD0983F35Q35105960-6290B9D5-43F4-4ADD-96BC-CD6AA95B0E40Q35216500-FFB11B3E-3DBA-4A38-8BD1-5338D6935CCEQ35218071-6EA00704-FC84-40D8-9993-ED11E2B972CCQ35297743-EAC1F871-8EF0-4F4B-80D0-DD44FAF8C7B2Q35379053-01C2F7FB-8887-4692-B8B8-A46B84C52DDEQ35457068-1331339D-E87E-48FB-9C51-0191BEAE2368Q35618481-9C301835-D0B3-4C5C-B2C0-FCBDA352F1DEQ35664367-D566B97B-088F-4A12-BFCC-DE0EB0592B38Q35670488-76BF20C0-C177-4A94-A355-C4B6EBFE30D7Q35753432-8460E5DA-3D62-4093-92D2-5C50297795BEQ35842780-156D5A33-72D6-4C38-B7EF-908DFBAFD538Q35960662-63DEE8DD-A4BD-4B40-865C-1A05BD4F04AFQ35966554-CE681C01-C176-40EF-AB5F-2D2DB2D59616
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Carbapenems: past, present, and future
@ast
Carbapenems: past, present, and future
@en
Carbapenems: past, present, and future
@nl
type
label
Carbapenems: past, present, and future
@ast
Carbapenems: past, present, and future
@en
Carbapenems: past, present, and future
@nl
prefLabel
Carbapenems: past, present, and future
@ast
Carbapenems: past, present, and future
@en
Carbapenems: past, present, and future
@nl
P2860
P3181
P356
P1476
Carbapenems: past, present, and future
@en
P2093
Andrea Endimiani
Magdalena A Taracila
P2860
P304
P3181
P356
10.1128/AAC.00296-11
P407
P577
2011-11-01T00:00:00Z